Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-238-0 | CAS number: 136-30-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitizing potential of sodium dibuthyldithiocarbamate (SDBC) in its manufactured and marketed form (as ca. 47% aqueous solution) was studied in a GLP-compliant mouse Local Lymph Node assay (LLNA). The Stimulation Indices (SI) were 1.1, 2.4 and 7.7 for 10, 25 and 50% test concentrations of the substance (as manufactured) in dimethylformamide (DMF), respectively, suggesting that sodium dibutyldithiocarbamate is sensitizing to skin. The EC3% estimated to be 27.8%.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA-J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: approx. 11 weeks old
- Weight at study initiation: within +/- 20% of the sex mean
- Housing: Individually in labeled Macrolon cages (MI type; height 12.5 cm) containing sterilized sawdust as bedding material (Litalabo, S.P.P.S., Argenteuil, France). Paper (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom) was supplied as cage-enrichment. The paper was removed on Day 1 prior to dosing and was supplied again after scoring of the ears on Day 3.
- Diet: pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany, ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.7– 22.9
- Humidity (%): 38-81
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12 - Vehicle:
- dimethylformamide
- Concentration:
- 0, 10, 25 and 50% (of the substance as manufactured, i.e. 46.20% aqueous solution)
- No. of animals per dose:
- 5 females/dose
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: the vehicle was selected based on trial formulations performed at NOTOX and on test substance data supplied by the sponsor
- Irritation: a preliminary irritation study was conducted in order to select the highest test substanceconcentration to be used in the main study. In principle, this concentration should be well tolerated systemically by the animals and may give moderate irritation (maximally grade 2 at the highest concentration.
Two test substance concentrations were tested; a 50% and 100% concentration. The highest concentration was the maximum concentration as required in the test guidelines (undiluted for liquids). After a single application of the test substance, the animal treated at 100% was found dead on Day 1 and no abnormalities were noted at necropsy. After 3 days of treatment, the animal at 50% showed no signs of systemic toxicity and the ears of this animal showed no severe irritation.
- Lymph node proliferation response: not determined
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: Stimulation Index (SI) calculated for each group. If the results indicate a SI ≥ 3, the test substance may be regarded as a skin sensitizer, based on the test guideline and recommendations done by ICCVAM
TREATMENT PREPARATION AND ADMINISTRATION: the dorsal surface of both ears was epidermally treated (25 μL/ear) with the test substance
concentration, at approximately the same time per day. The concentrations were mixed thoroughly using a vortex mixer immediately prior to dosing. The control animals were treated the same as the experimental animals, except that the vehicle was administered instead of the test substance. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Key result
- Parameter:
- EC3
- Value:
- 27.8
- Remarks on result:
- other: in %
- Parameter:
- SI
- Value:
- 1.1
- Test group / Remarks:
- 10%
- Remarks on result:
- other: 10%
- Parameter:
- SI
- Value:
- 2.4
- Test group / Remarks:
- 25%
- Remarks on result:
- other: 25%
- Parameter:
- SI
- Value:
- 7.7
- Test group / Remarks:
- 50%
- Remarks on result:
- other: 50%
- Cellular proliferation data / Observations:
- 847, 929, 2063 and 6559 DPM for 0 (vehicle), 10, 25 and 50% test substance concentrations.
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- Based on this result SDBC (47% aqueous solution) shall be considered as a skin sensitizer.
- Executive summary:
In this Mouse LLNA the sensitization potential of Sodium dibutyldithiocarbamate (SDBC) (47% aqueous solution) was tested. The study was carried out based on the OECD guideline 429. Test substance concentrations selected for the main study were based on the results of a preliminary study. After a single application of the test substance, the animal treated with the 100% test substance concentration was found dead on Day 1 and no abnormalities were noted at necropsy. After 3 days of treatment, the animal at 50% showed no signs of systemic toxicity and the ears of this animal showed no severe irritation. In the main study, three experimental groups of five female CBA/J mice were treated with test substance concentrations of 10, 25 or 50% w/w on three consecutive days, by open application on the ears. Five vehicle control animals were similarly treated, but with vehicle alone (Dimethyl formamide). Three days after the last exposure, all animals were injected with 3H-methyl thymidine and after five hours the draining (auricular) lymph nodes were excised and pooled for each animal. After precipitating the DNA of the lymph node cells, radioactivity measurements were performed. The activity was expressed as the number of Disintegrations Per Minute (DPM) and a stimulation index (SI) was subsequently calculated for each group.
Slight erythema of the ears was observed among animals treated at 25% and for all animals treated at 50%, but was considered not to have a toxicologically significant effect on the activity of the nodes. No erythema of the ears was observed for any of the animals at 10% or control animals and no oedema was observed in any of the animals examined. No mortality occurred and no symptoms of systemic toxicity were observed in the animals of the main study. Body weights and body weight gain of experimental animals remained in the same range as controls over the study period. Auricular lymph nodes of all animals treated at 50% were considered enlarged and auricular lymph
nodes of all control animals and animals at 10 and 25% were considered normal in size. No macroscopic abnormalities of the surrounding area were noted in any of the animals. Mean DPM/animal values for the experimental groups treated with test substance concentrations 10, 25 and 50% were 929, 2063 and 6559 DPM respectively. The mean DPM/animal value for the vehicle control group was 847 DPM. The SI values calculated for the 10, 25 and 50% concentrations of the solution were 1.1, 2.4 and 7.7 respectively. These results indicate that the test substance could elicit an SI ≥ 3. The data showed a dose-response and an EC3 value of 27.8% was calculated. Based on these results SDBC (47% aqueous solution) is a skin sensitizer.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
Skin sensitizing potential of sodium dibuthyldithiocarbamate (SDBC) in its manufactured and marketed form (as ca. 47% aqueous solution) was studied in a GLP-compliant mouse Local Lymph Node assay (LLNA). Groups of 5 female CDA/J mice were epidermally treated (25 μL/ear) with 10, 25 and 50% of the test substance (as manufactured) in DMF. The control group was treated with the same amount of vehicle only. Each animal was injected via the tail vein with 0.25 mL of sterile phosphate buffered saline (PBS) containing 20 μCi of 3H-methyl thymidine. After approximately five hours, all animals were sacrificed and the draining lymph node of each ear was excised to determine the number of desintegrations per minute (DPM) by scintillation counter. The stimulation indices (SI; ratio DPM for test group to DPM for control group) were determined for each dose level. The SI were 1.1, 2.4 and 7.7 for 10, 25 and 50% test concentrations, respectively, respectively, suggesting that sodium dibuthyldithiocarbamate is sensitizing to skin.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The test substance is not expected to be of concern for respiratory sensitisation. Following the recommended approach outlined in R.7.3.12.3, the test substance is not expected to be a respiratory sensitiser because the test substance is not di-isocyanate or protein. Furthermore, no structural warnings for respiratory sensitisation were found using the QSAR toolbox (v4.4).
Justification for classification or non-classification
Based on the Stimulation Index of 7.7 for 50% test substance (as 46.2% aqueous solution) in Local Lymph Node Assay, the test substance should be classified as sensitizing to skin (Skin Sens.1, H317) (may cause an allergic skin reaction) in accordance with EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008. It is obvious that pure substance should also be considered as a skin sensitizer and classified and labelled accordingly. Accordingly, the anhydrous form of SDBC shall be assigned the same classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.